NEW YORK, Oct. 18 – Roche Diagnostics and Quest Diagnostics have penned a deal to jointly develop gene-based tests to predict a person’s likelihood of developing particular diseases and to evaluate the best course of treatment.

The companies said they would work together to commercialize gene-based markers to determine a person’s risk for stroke or asthma.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.